Yanfang Lu

1.1k total citations
30 papers, 832 citations indexed

About

Yanfang Lu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Yanfang Lu has authored 30 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Yanfang Lu's work include Immune Cell Function and Interaction (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Escherichia coli research studies (4 papers). Yanfang Lu is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Escherichia coli research studies (4 papers). Yanfang Lu collaborates with scholars based in China, United States and Australia. Yanfang Lu's co-authors include Hongyan Hou, Qi Feng, Dongwei Liu, Zhangsuo Liu, Lie Mao, Yu Zhou, Liyan Mao, Sun Ziyong, Ziyong Sun and Shiji Wu and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Yanfang Lu

27 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfang Lu China 17 279 272 141 118 116 30 832
Xiaoxue Ma China 14 479 1.7× 198 0.7× 340 2.4× 108 0.9× 40 0.3× 37 1.1k
Guangyong Sun China 20 239 0.9× 431 1.6× 83 0.6× 207 1.8× 95 0.8× 53 1.2k
Amy Y. Tang United States 8 828 3.0× 424 1.6× 74 0.5× 83 0.7× 47 0.4× 11 992
Xiang‐Qing Yu United States 16 498 1.8× 179 0.7× 237 1.7× 154 1.3× 61 0.5× 21 980
Mary Speir Australia 13 408 1.5× 295 1.1× 79 0.6× 26 0.2× 58 0.5× 15 708
Chunwei Shi China 19 370 1.3× 248 0.9× 263 1.9× 19 0.2× 98 0.8× 37 950
Urvashi Bhan United States 19 219 0.8× 522 1.9× 131 0.9× 36 0.3× 46 0.4× 22 951
Adam Carlson United States 10 396 1.4× 335 1.2× 70 0.5× 16 0.1× 91 0.8× 11 735
Yuling Wu United States 17 385 1.4× 303 1.1× 201 1.4× 60 0.5× 27 0.2× 32 849
Brandon Tan United States 14 432 1.5× 237 0.9× 101 0.7× 244 2.1× 154 1.3× 21 902

Countries citing papers authored by Yanfang Lu

Since Specialization
Citations

This map shows the geographic impact of Yanfang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfang Lu more than expected).

Fields of papers citing papers by Yanfang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfang Lu. The network helps show where Yanfang Lu may publish in the future.

Co-authorship network of co-authors of Yanfang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfang Lu. A scholar is included among the top collaborators of Yanfang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfang Lu. Yanfang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lina, Yanfang Lu, Yanliang Wang, et al.. (2025). Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC. Frontiers in Immunology. 16. 1615601–1615601.
2.
Li, Na, et al.. (2025). Identification of key genes in membranous nephropathy and non-alcoholic fatty liver disease by bioinformatics and machine learning. Frontiers in Immunology. 16. 1564288–1564288. 1 indexed citations
4.
Zhang, Lina, et al.. (2025). Unveiling PANoptosis in Acute Kidney Injury: An Integrative Multi-Dimensional Approach to Identify Key Biomarkers. Journal of Inflammation Research. Volume 18. 8735–8754.
5.
Lu, Yanfang, Miao Liu, Jennifer Yang, et al.. (2021). Spatial transcriptome profiling by MERFISH reveals fetal liver hematopoietic stem cell niche architecture. Cell Discovery. 7(1). 47–47. 43 indexed citations
6.
Feng, Qi, Dongwei Liu, Yanfang Lu, & Zhangsuo Liu. (2020). The Interplay of Renin‐Angiotensin System and Toll‐Like Receptor 4 in the Inflammation of Diabetic Nephropathy. Journal of Immunology Research. 2020(1). 6193407–6193407. 54 indexed citations
7.
Lu, Yanfang, Dongwei Liu, Qi Feng, & Zhangsuo Liu. (2020). Diabetic Nephropathy: Perspective on Extracellular Vesicles. Frontiers in Immunology. 11. 943–943. 96 indexed citations
8.
Liu, Miao, Yanfang Lu, Bing Yang, et al.. (2020). Multiplexed imaging of nucleome architectures in single cells of mammalian tissue. Nature Communications. 11(1). 2907–2907. 73 indexed citations
9.
Mao, Liyan, Zhongju Chen, Yanfang Lu, et al.. (2018). Helcococcus ovis in a patient with an artificial eye: a case report and literature review. BMC Infectious Diseases. 18(1). 401–401. 5 indexed citations
10.
Zhou, Yu, Xuhui Zhu, Hongyan Hou, et al.. (2018). Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea: a hospital based study. BMC Infectious Diseases. 18(1). 63–63. 86 indexed citations
12.
Wu, Jing, et al.. (2017). Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant Escherichia coli. Frontiers in Microbiology. 8. 2294–2294. 44 indexed citations
13.
Hou, Hongyan, Lie Mao, Yanfang Lu, et al.. (2017). The performance of the TBAg/PHA ratio in the diagnosis of active TB disease in immunocompromised patients. International Journal of Infectious Diseases. 59. 55–60. 19 indexed citations
14.
Li, Bin, et al.. (2017). Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital. Antimicrobial Resistance and Infection Control. 6(1). 118–118. 25 indexed citations
15.
Zhou, Yu, Juan Du, Hongyan Hou, et al.. (2017). Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy. Frontiers in Cellular and Infection Microbiology. 7. 457–457. 19 indexed citations
16.
Lu, Yanfang, Hongyan Hou, Feng Wang, et al.. (2016). ATP1B3: a virus-induced host factor against EV71 replication by up-regulating the production of type-I interferons. Virology. 496. 28–34. 19 indexed citations
17.
Hou, Hongyan, Lie Mao, Juan Wang, et al.. (2016). Establishing the reference intervals of NK cell functions in healthy adults. Human Immunology. 77(8). 637–642. 11 indexed citations
18.
Wang, Feng, Hongyan Hou, Shiji Wu, et al.. (2015). Tim-3 pathway affects NK cell impairment in patients with active tuberculosis. Cytokine. 76(2). 270–279. 19 indexed citations
19.
Hou, Hongyan, Weiyong Liu, Shiji Wu, et al.. (2014). Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock. PLoS ONE. 9(10). e110585–e110585. 32 indexed citations
20.
Liu, Cailin, et al.. (2014). Vancomycin intermediate-Resistant Staphylococcus aureus (VISA) Isolated from a patient who never received Vancomycin treatment. International Journal of Infectious Diseases. 33. 185–190. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026